Hongzhou Lu
- Virology top 10%
- HIV Research and Treatment 8
- Infectious Diseases top 10%
- HIV/AIDS Research and Interventions 7
- Antifungal resistance and susceptibility 3
- HIV/AIDS drug development and treatment 3
-
- Fungal Infections and Studies 3
- Cytomegalovirus and herpesvirus research 3
-
- Infectious Diseases and Tuberculosis 2
-
- Immune Response and Inflammation 2
- Journals
- PLoS ONE (1 paper)Journal of Clinical Microbiology (1 paper)Frontiers in Immunology (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Hongzhou Lu
19 papers receiving 273 citations
Peers
Comparison fields: 5 of 62
- Virology 56
- Infectious Diseases 155
- Emergency Medicine 38
- Epidemiology 127
- Biological Psychiatry 7
Countries citing papers authored by Hongzhou Lu
This map shows the geographic impact of Hongzhou Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongzhou Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongzhou Lu more than expected).
Fields of papers citing papers by Hongzhou Lu
This network shows the impact of papers produced by Hongzhou Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongzhou Lu. The network helps show where Hongzhou Lu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hongzhou Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 4 | |
| 6 | 2025 | 0 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 0 | |
| 9 | 2023 | 1 | |
| 10 | 2021 | 17 | |
| 11 | 2021 | 13 | |
| 12 | 2020 | 8 | |
| 13 | 2017 | 30 | |
| 14 | 2017 | 15 | |
| 15 | 2016 | 53 | |
| 16 | 2015 | 7 | |
| 17 | 2014 | 22 | |
| 18 | 2012 | 3 | |
| 19 | 2011 | 18 | |
| 20 | 2005 | 45 |
About Hongzhou Lu
Hongzhou Lu is a scholar working on Virology, Infectious Diseases and Emergency Medicine, having authored 24 papers that have together received 278 indexed citations. Recurring topics across this work include HIV Research and Treatment (8 papers), HIV/AIDS Research and Interventions (7 papers), Antifungal resistance and susceptibility (3 papers), Fungal Infections and Studies (3 papers), Cytomegalovirus and herpesvirus research (3 papers), HIV/AIDS drug development and treatment (3 papers), Infectious Diseases and Tuberculosis (2 papers) and Immune Response and Inflammation (2 papers). The work is most often cited by research in Virology (56 citations), Infectious Diseases (155 citations) and Emergency Medicine (38 citations). Hongzhou Lu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Yongjia Ji, Li Liu, Xinhua Weng, Renfang Zhang, Yingjie Zhou, Tangkai Qi, Jianjun Sun, Yinzhong Shen, Yang Tang and Meiyan Sun. Their work appears in journals such as PLoS ONE, Journal of Clinical Microbiology and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.